Overview

Corporate Profile

Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases. We harness our cell expansion platform to create therapies with the potential to redefine standards of care in areas of serious medical need.

Nov 29, 2020
11:03 AM EST

Change
Volume
52-Wk High
52-Wk Low

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Latest News

View All

Nov 24, 2020

Gamida Cell to Present at Upcoming Conferences

Nov 10, 2020

Gamida Cell Reports Third Quarter 2020 Financial Results and Provides Company Update

Nov 04, 2020

Gamida Cell Announces Data to Be Presented at 62nd ASH Annual Virtual Meeting

Nov 04, 2020

Gamida Cell to Present at H.C. Wainwright 6th Annual Israel Conference

Nov 02, 2020

Gamida Cell Announces the Date of Its Third Quarter 2020 Financial Results and Webcast

Oct 13, 2020

Gamida Cell and Be The Match BioTherapies® Expand Strategic Collaboration

Oct 07, 2020

Gamida Cell to Present at 2020 Virtual Cell & Gene Meeting on the Mesa

Oct 06, 2020

Gamida Cell Announces Positive Topline Data on Secondary Endpoints from Phase 3 Clinical Study of Omidubicel in Patients with Hematologic Malignancies

Sep 10, 2020

Gamida Cell Presents Analysis of Observational Data Demonstrating the Impact of Donor Age in Hematopoietic Stem Cell Transplant Outcomes at the Virtual Cord Blood Connect Meeting

Sep 08, 2020

Gamida Cell to Participate in Upcoming Investor Conferences

Sep 03, 2020

Gamida Cell Announces Two-Part Virtual Miniseries Focused on Omidubicel to Take Place in September

Aug 17, 2020

Gamida Cell to Provide Webcast of Its Annual Meeting of Stockholders

Aug 11, 2020

Gamida Cell Reports Second Quarter 2020 Financial Results and Provides Company Update

Aug 04, 2020

Gamida Cell Announces the Date of Its Second Quarter 2020 Financial Results and Webcast

Jul 21, 2020

Gamida Cell Announces Appointment of Michele Korfin as Chief Operating and Chief Commercial Officer

Jul 07, 2020

Gamida Cell Announces Appointment of David Fox to Its Board of Directors

Jun 12, 2020

Gamida Cell to Present at the JMP Securities Virtual Hematology and Oncology Forum

May 26, 2020

Gamida Cell Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

May 21, 2020

Gamida Cell Reports First Quarter 2020 Financial Results and Provides Company Update

May 18, 2020

Gamida Cell Announces Pricing of $60 Million Public Offering of Ordinary Shares

Upcoming Events

Dec 3, 2020 at 12:10 PM EST

Evercore ISI 3rd Annual HealthCONx Conference

Add to Outlook

Add to Google Calendar

Listen to webcast

All Events

Recent Events

Nov 23, 2020 at 10:00 AM EST

Piper Sandler HC Conference